"India started working on a vaccine from April soon after the pandemic broke out abroad. At least three companies are working on the vaccine. One company has made real progress and we believe by November, we will have something in hand," he added.
Adding that what happens abroad is not any of India's concerns, he said India will be among the first few countries to have such a vaccine to tackle the H1N1 virus.
Katoch informed that Serum Institute of India, Pune, Bharat Biotech, Hyderabad and Panacea Biotech, New Delhi are working on developing the vaccine.
Serum Institute has made real progress in developing the 'egg-based' vaccine while the other two are developing 'cell line vaccines'
"After the animal trials at the above three companies, the vaccine will go for human trials. May be by November we will do some human trials," he said.
The secretary who is a leading health secretary himself said that the trials will be conducted in multiple centres and and 'Some may be outside India too.'
The vaccine will see 'fast track approval'. However, the quality will not be compromised with and all 'safety measures' shall be taken, he assured.